Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Apogee Therapeutics Inc | 2,048,647 | 2,048,647 | 0 | $76.54M | $88.97M | 11.53% | +$12.44M |
| Axsome Therapeutics, Inc.(AXSM) | 815,176 | 815,176 | 0 | $95.07M | $85.10M | 11.02% | -$9.98M |
| Enliven Therapeutics Inc | 3,202,798 | 3,711,444 | +508,646 | $63.03M | $74.45M | 9.65% | +$11.42M |
| Scholar Rock Holding Corporation(SRRK) | 1,374,031 | 1,824,031 | +450,000 | $44.18M | $64.61M | 8.37% | +$20.43M |
| Spyre Therapeutics, Inc.(SYRE) | 4,018,101 | 4,018,101 | 0 | $64.83M | $60.15M | 7.79% | -$4.68M |
| Nuvalent Inc | 727,563 | 727,563 | 0 | $51.60M | $55.51M | 7.19% | +$3.91M |
| Dianthus Therapeutics, Inc.(DNTH) | 2,700,691 | 2,707,191 | +6,500 | $48.99M | $50.43M | 6.53% | +$1.44M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 1,102,248 | 1,772,839 | +670,591 | $24.48M | $49.05M | 6.36% | +$24.57M |
| Viridian Therapeutics, Inc.(VRDN) | 3,445,813 | 3,459,913 | +14,100 | $46.45M | $48.37M | 6.27% | +$1.92M |
| Cogent Biosciences, Inc.(COGT) | 6,225,641 | 6,225,641 | 0 | $37.29M | $44.70M | 5.79% | +$7.41M |
| Oruka Therapeutics, Inc.(ORKA) | 3,371,922 | 3,371,922 | 0 | $34.60M | $37.80M | 4.90% | +$3.20M |
| Jade Biosciences Inc | 0 | 3,220,368 | +3,220,368 | $0 | $32.17M | 4.17% | +$32.17M |
| Crescent Biopharma, Inc.(CBIO) | 0 | 1,387,866 | +1,387,866 | $0 | $22.40M | 2.90% | +$22.40M |
| Astria Therapeutics Inc | 3,554,129 | 3,554,129 | 0 | $18.98M | $19.05M | 2.47% | +$71.1K |
| Zenas BioPharma, Inc.(ZBIO) | 1,892,806 | 1,892,806 | 0 | $14.95M | $18.34M | 2.38% | +$3.39M |
| Inhibikase Therapeutics, Inc.(IKT) | 6,125,000 | 6,125,000 | 0 | $13.41M | $11.94M | 1.55% | -$1.47M |
| CytomX Therapeutics, Inc.(CTMX) | 0 | 3,896,582 | +3,896,582 | $0 | $8.85M | 1.15% | +$8.85M |
| Bicara Therapeutics Inc | 784,170 | 0 | -784,170 | $10.22M | $0 | — | -$10.22M |